Research Topics
Genomes and GenesSpecies | Salut BrunetSummaryAffiliation: Hospital de la Santa Creu i Sant Pau Country: Spain Publications
| Collaborators
|
Detail Information
Publications
Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategySalut Brunet
Hematology Department, Hospital de la Sant Creu i Sant Pau, Barcelona, Spain
Haematologica 89:940-9. 2004..To evaluate a regimen of induction and consolidation chemotherapy, followed by a post-remission therapy which depended on age and cytogenetics, in patients with primary acute myeloid leukemia...
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experienceJosé Luis Piñana
Clinical Hematology and Hematopoietic Transplantation Division, Autonomous University of Barcelona, Barcelona, Spain
Biol Blood Marrow Transplant 15:21-9. 2009..05). ARF is a frequent complication in patients after Allo-RIC, and it has a negative impact on outcome. Identification of ARF risk factors could help to avoid exposure to nephrotoxic drugs during the follow-up in patients at high risk...
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapyA Perez-Garcia
Hematology Department, Institut Catalàd Oncologia, Girona, L Hospitalet and Badalona, Spain
Leukemia 23:486-91. 2009..64, 95% confidence interval (CI)=1.36-5.14) and lower overall survival at 3 years (39.4 vs 68.4%, P=0.004; HR=2.80, 95% CI=1.39-5.64). This is the first study to report an association between polymorphisms at CTLA-4 and AML relapse...
Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioningLuca Facchini
Hematology Department of the Hospital de la Santa Creu I Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
Eur J Haematol 88:46-51. 2012..We analyzed the risk factors (RFs) for the development of FN and SBI in the first 100d post-transplant in 195 consecutive adult recipients of a reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation (RIC-allo)...
Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing aPere Barba
Hematology and Stem Cell Transplantation Division Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain
Biol Blood Marrow Transplant 16:413-20. 2010..In conclusion, our single-center study suggests that the flexible HCT-CI is a good predictor of 2-year NRM and survival after an allo-RIC...
High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patientsAlbert Oriol
Department of Hematology, ICO Hospital Universitari Germans Trias i Pujol, Badalona Autonomous University, Barcelona, Spain
Cancer 113:117-25. 2008..The introduction of rituximab in BL therapeutic schemes has been scarcely explored. The outcome and toxicity of HIV-positive patients with BL treated in a rituximab and intensive chemotherapy-based trial was evaluated...
High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemiasAdriana Lasa
Department of Hematology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
Ann Hematol 87:205-11. 2008..It remains to be investigated whether these CEACAM disturbances provide growth advantages to tumoral cells by inhibiting the anoikis process...
Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcomeJosé Luis Piñana
Hematology and Stem Cell Transplantation Division, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Am J Hematol 87:9-14. 2012..8, 95% CI. 0.98-3.6, P = 0.06 and HR 1.7, 95% CI. 1.1-2.6, P = 0.008). This study emphasizes the valuable role of PFTs in identifying patients at risk for PPC, NRM, and lower OS in the Allo-RIC setting...
Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell selectioCarmen Canals
Clinical Hematology Division, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Exp Hematol 31:1039-43. 2003..The aim of this study was to compare two approaches used to reduce transplant-related mortality (TRM) after allogeneic peripheral blood stem cell transplantation (allo-PBSCT) in elderly patients...
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemiaMariano Monzo
Hospital Clinic, Hospital Universitario de la Santa Creu i Sant Pau, Barcelona, Spain
Blood 107:4871-9. 2006..4; P = .02) and MDR1 (RR = 2.1; P = .02) variant alleles, and WBC count (RR = 2.1; P = .02). These findings might be useful in selecting risk-adapted treatment strategies in intermediate-risk AML...
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemiaDavid Valcarcel
Hematology Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain
Cancer 118:410-7. 2012..A prognostic index to predict induction death in adult patients receiving induction chemotherapy for de novo acute myeloid leukemia (AML) was developed...
Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphomaInigo Espinosa
Department of Pathology, Hospital de la Santa Creu i Sant Pau, Universidad Autonoma de Barcelona, Barcelona, Spain
Ann Hematol 85:597-603. 2006..4, P=0.011). Our results suggest that membrane expression of PKC-beta 2 protein on DLBCL predicts for poor survival, especially in patients with low IPI...
Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host diseaseJosé Luis Piñana
Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
Biol Blood Marrow Transplant 12:1135-41. 2006....
Microsatellite instability is not an uncommon finding in adult de novo acute myeloid leukemiaJosep F Nomdedeu
Department of Hematology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
Ann Hematol 84:368-75. 2005..hMLH1 promoter was hypermethylated in five MSI+ cases. Overall survival analysis revealed no adverse effect of MSI positivity. These results suggest that MSI may be a common biologic finding in de novo AML...
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblingsAlvaro Urbano-Ispizua
Department of Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain
Blood 100:724-7. 2002....
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study GroupAlbert Oriol
Servei d Hematologia Clinica, Institut Catala d Oncologia, Hospital Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain
Haematologica 95:589-96. 2010..The objective of this study was to explore the factors influencing the outcome of adult patients with relapsed acute lymphoblastic leukemia...
Comparison of CHOP treatment with specific short-intensive chemotherapy in AIDS-related Burkitt's lymphoma or leukemiaBlanca Xicoy
Institut Català d Oncologia Hospital Universitari Germans Trias i Pujol and Institut de Recerca Contra la Leucèmia Josep Carreras, Badalona, Universitat Autonoma de Barcelona, Barcelona, Spain
Med Clin (Barc) 136:323-8. 2011..This retrospective study aimed to compare the results of CHOP with those from two protocols (PETHEMA-LAL3/97 and BURKIMAB) of specific therapy in Spain...
K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML)Maria J Carnicer
Department of Hematology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
Ann Hematol 87:819-27. 2008..K313dup seems to be selected in leukemic cells, and its frequency in other AML series could be determined using the screening method reported in this paper...
Early clinical impact of iron overload in stem cell transplantation. A prospective studyAlbert Altes
Department of Haematology, Hospital de Sant Pau, Autonomous University of Barcelona, Barcelona, Spain
Ann Hematol 86:443-7. 2007..In conclusion, iron burden seems to influence the appearance of toxic-infectious complications during the first 3 months after transplant in AUTO-transplanted patients...
Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signaturesElena Serrano
Laboratori d'Hematologia, Hospital de la Santa Creu i Sant Pau, , Barcelona, Spain
Acta Haematol 116:77-89. 2006..In accordance with previous results, Meis1 downregulation is a useful surrogate marker indicating a good prognosis in AML patients. Simple qPCR platforms may help to identify different biologic subgroups in AML...
Epidemiology of aplastic anemia: a prospective multicenter studyEva Montané
Fundacio Institut Catala de Farmacologia, Barcelona, Spain
Haematologica 93:518-23. 2008..Aplastic anemia is a rare and severe disease. Its incidence varies considerably worldwide. We aimed at describing the epidemiology of this disease, including the incidence, mortality and survival trends, in a well-defined population...
Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioningRodrigo Martino
Division of Clinical Hematology, Hospital de la Sant Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
Biol Blood Marrow Transplant 11:437-47. 2005..In conclusion, therapeutic dose monitoring of oral Bu in a reduced-intensity conditioning setting does not seem to affect outcome, although further studies may identify very-high-risk patients who benefit from this strategy...
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donorsArianne Perez-Garcia
Clinical Hematology Department, Alloreactivity Unit, Laborateri de Recerca Translacional, Institut Catala d Oncologia, Hospital Duran i Reynals, Barcelona, Spain
Blood 110:461-7. 2007..03-2.29). This is the first study to report an association between polymorphisms at CTLA-4 and clinical outcome after allo-HSCT. The CT60 genotype influences relapse and aGVHD, probably due to its action on CTLA-4 alternative splicing...
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rateJulio Delgado
Department of Haematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Br J Haematol 145:801-5. 2009..In all survival models, B2M did not attain independent significance unless GFR-B2M was eliminated from the analysis. In conclusion, GFR-B2M is a better predictor of TFS than unadjusted B2M in CLL patients...
A celecoxib derivative inhibits focal adhesion signaling and induces caspase-8-dependent apoptosis in human acute myeloid leukemia cellsIsolda Casanova
Networking Research Center on Bioengineering, Biomaterials and Nanomedicine CIBER BBN, Barcelona, Spain
Int J Cancer 123:217-26. 2008..Finally, our results support the evaluation of celecoxib in AML patients, and the preclinical evaluation of E7123, before its possible clinical testing...
International and Italian prognostic indices in follicular lymphomaGranada Perea
Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Haematologica 88:700-4. 2003..The Italian Lymphoma Intergroup (ILI) created a new prognostic index specific for FL. The aim of this study was to compare which of these two indices is more useful when applied to a large group of FL patients...
Bone marrow necrosis with Charcot-Leyden crystals in a patient with idiopathic hypereosinophilic syndromeNuria Pujol-Moix
Departament d Hematologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Haematologica 88:EIM12. 2003
Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patientsRodrigo Martino
Division of Clinical Hematology, Hospital de la Sant Creu i Sant Pau, Barcelona, Spain
Br J Haematol 116:475-82. 2002..Prophylactic strategies for these infections should thus take into account these risk factors...
Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromesRodrigo Martino
Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Av Sant Antoni Maria Claret, 167 08025 Barcelona, Spain
Blood 100:2243-5. 2002..008). These results suggest that a graft-versus-leukemia effect plays a crucial role in reducing the risk of relapse after a RIC allograft in AML and MDS...
Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factorsMaricel Subirá
Servei d Hematologia Clinica, Hospital de la Santa Creu i Sant Pau, Av S A M Claret 167, 08025 Barcelona, Spain
Haematologica 87:528-34. 2002..In this retrospective study we have reviewed all consecutive cases of IPA diagnosed in adult patients with hematologic malignancies in our center from 1995 to 2000 to determine survival and prognostic factors...
Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantationJosep Maria Ribera
Department of Haematology, ICO Hospital Germans Trias i Pujol, Jose Carreras Leukaemia Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain
Br J Haematol 159:78-81. 2012..78%). The reduction in early death, relapse before SCT and transplant-related mortality observed in the ALL-Ph-08 trial resulted in an improved 2-year event-free survival (63% vs. 37%, P = 0·009)...
Hla-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host diseaseDavid Gallardo
Alloreactivity Unit of the Institut Català d Oncologia, Barcelona, Spain
Transplantation 77:1107-10. 2004..A higher incidence of acute graft-versus-host disease (aGVHD) has been described after unrelated donor bone marrow transplant when both HLA-DPB1 alleles were mismatched...
Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 studyAlbert Oriol
Servei d'Hematologia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
Haematologica 88:445-53. 2003..It also shows the feasibility of these strategies in individuals with HIV infection with comparable results. Advanced age proved to be the main adverse prognostic factor for response to therapy and survival...
Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantationFederico Moscardo
Hematology Department, Hospital Universitario La Fe, Avda Campanar 21, 46009 Valencia, Spain
Exp Hematol 31:545-50. 2003..However, no comparative studies have been performed to investigate this. We analyzed the influence of selection for CD34(+) cells on the incidence and severity of hepatic veno-occlusive disease (VOD)...
CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: high purging efficiency but increased risk of severe infectionsAlbert Altes
Clinical Hematology Division, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain
Exp Hematol 30:824-30. 2002..The main objective of this work was to decrease the incidence of relapse after autologous stem cell transplantation with a "double purging" procedure...
Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxisPau Montesinos
Hematology Department, Hospital Universitario La Fe, Avda Campanar 21, Valencia, Spain
Haematologica 94:1242-9. 2009..The prevalence of and risk factors for central nervous system recurrence in patients with acute promyelocytic leukemia are not well established and remain a controversial matter...
Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantationMiguel A Diaz
Spanish Group for Allogeneic Peripheral Blood Stem Cell Transplantation
Haematologica 88:919-22. 2003..In this study we analyzed predictive factors for PBPC collection in pediatric donors...
Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantationLuis Villela
Servei d Hematologia Clinica, Hospital de la Santa Creu i Sant Pau, Antoni Maria i Claret 167, 08025 Barcelona, Spain
Haematologica 88:300-5. 2003..We evaluated the results of ASCT in a group of 49 patients >= 60 years of age [32 males, median age 63 years (range, 60 to 71)] autografted in our institution from January 1995 to December 2001...
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantationJose A Perez-Simon
Department of Hematology, Hospital Clinico Universitario, Salamanca, Spain
Blood 102:1108-13. 2003....
Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yieldsJavier de la Rubia
Spanish Group of Allogeneic Peripheral Blood Stem Cell Transplantation, La Fe University Hospital, 4600 Valencia, Spain
J Hematother Stem Cell Res 11:705-9. 2002..057). Our study shows that second rounds of PBPC collection from normal donors are well tolerated but are associated with a significantly reduced number of CD34(+) cells collected when the same mobilization scheme is used...
Analysis of factors associated with low peripheral blood progenitor cell collection in normal donorsJavier de la Rubia
Hematology Service, Hospital La Fe, Valencia, Spain
Transfusion 42:4-9. 2002..Predictive factors of the response to rHuG-CSF in normal donors have not been extensively studied...
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantationJose A Perez-Simon
Servicio de Hematlogía, Hospital Clinico Universitario, Salamanca, Spain
Br J Haematol 130:394-403. 2005....
Oral induction and consolidation chemotherapy with idarubicin and etoposide in elderly patients with acute myeloid leukemiaAlbert Oriol
Haematologica 88:229-30. 2003
Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 studyAlbert Oriol
Haematologica 90:990-2. 2005..051). We extended the follow-up analysis to elucidate the role of HAART in the survival of HIV-infected patients included in the PETHEMA-LAL3/97 protocol...
Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemiaSilvia Casas
Department of Hematology, Hospital Sant Pau Autonomous University of Barcelona, Avda Sant Antoni Ma Claret 167, Barcelona 08025, Spain
Cancer Genet Cytogenet 153:16-25. 2004..Application of the CGH technique is thus a useful complementary diagnostic tool for CCA in de novo AML cases with abnormal karyotypes or with unsuccessful cytogenetics...
Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessmentRaymond Miralbell
University Hospital of Geneva, Geneva, Switzerland
Int J Radiat Oncol Biol Phys 58:809-16. 2004..A study was undertaken to assess prospectively the subclinical renal function changes with radioisotopic methods in patients undergoing BMT for hematologic malignancies...
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemiaJuan Manuel Sancho
Clinical Hematology Department, Institut Català d Oncologia Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Eur J Haematol 78:102-10. 2007..We present the results of treatment of Philadelphia chromosome-negative (Ph-) ALL patients over 55 yr treated in the PETHEMA ALL-96 trial...
FLT3 mutations are associated with other molecular lesions in AMLMaria J Carnicer
Laboratori d Hematologia, Hospital de la Santa Creu i Sant Pau, Avda Sant Antoni M Claret, 167, 08025 Barcelona, Spain
Leuk Res 28:19-23. 2004..4% of patients showed Class I + Class II mutations. Our findings could be consistent with the cooperative model. The search for new tyrosine kinases which can be the target of molecular lesions in AML warrants further investigation...
Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemiaPascual Bolufer
Laboratory of Molecular Biology Medical Biopathology, Hospital Universitario La Fe, Valencia, Spain
Br J Haematol 136:590-6. 2007..42, 95% CI = 1.59-212.76, P = 0.02 respectively). Thus, the profiles of genetic polymorphisms of drug-metabolising enzymes might explain the increased risk to t-AML/t-MDS observed in some patients treated with polychemotherapy...
Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocolAlbert Oriol
CETLAM Group, Catalonia, Spain
Haematologica 89:791-800. 2004..We assessed the proportion of patients over 60 years with de novo AML who qualified for intensive therapy and determined the feasibility and results of autologous stem cell transplantation (ASCT) in first complete remission (CR)...
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host diseaseManuel Jurado
Department of Hematology, Hospital Virgen de las Nieves, Granada, Spain
Biol Blood Marrow Transplant 13:701-6. 2007..Further investigation is warranted to elucidate the role of sirolimus in cGVHD, and find the best combination (sirolimus + calcineurin inhibitors versus others) for therapeutic use...
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantationJohannes Schetelig
, , Germany
Haematologica 88:1272-8. 2003..INTERPRETATION AND CONCLUSIONS: There is evidence that AIL is susceptible to high-dose chemotherapy. HDCT and autologous stem cell transplantation should be considered in selected patients with AIL...
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicinJavier de la Serna
Hospital 12 de Octubre, Madrid, Spain
Blood 111:3395-402. 2008..These data furnish clinically relevant information that might be useful for designing more appropriately risk-adapted treatment protocols aimed at reducing the considerable problem of induction mortality in APL...
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial)Blanca Xicoy
Services of Hematology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Leuk Lymphoma 44:1541-3. 2003..Two patients died in induction, another died in consolidation phase and the remaining 2 patients are in continuous complete remission 6 and 18 months from the diagnosis...
Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotypeElena Serrano
Department of Haematology, Hospital de Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Spain
Leuk Lymphoma 49:1178-83. 2008..MSI involved the polymorphic PIG3 promoter in two UPD+ cases. It remains to be tested whether UPD and MSI association marks a common pathway of leukemogenesis...
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA GroupMiguel A Sanz
Hospital Universitario La Fe, Valencia, Spain
Blood 112:3130-4. 2008..04, respectively). This updated analysis confirms the high antileukemic efficacy, low toxicity, and high degree of compliance of a risk-adapted strategy combining ATRA and anthracycline monochemotherapy for consolidation therapy...
Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemiasElena Serrano
Department of Hematology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Spain
Leuk Res 32:944-53. 2008..Furthermore, some of the genes deregulated by the leukemogenic process reverted to their normal expression with demethylating and HDAC inhibitor treatment, highlighting the role of chromatin remodeling processes in AML...
